Ignite Creation Date:
2024-05-06 @ 3:19 PM
Last Modification Date:
2024-10-26 @ 1:47 PM
Study NCT ID:
NCT04595565
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-06-17
First Post:
2020-04-07
Brief Title:
Sacituzumab Govitecan in Primary HER2-negative Breast Cancer
Sponsor:
Organization:
German Breast Group